STDs and STIs are having a profound impact on sexual and reproductive health globally. Every year, there are an estimated 376 million new infections. Gonorrhoea, Chlamydia, Syphilis and Trichomoniasis are most commonly seen. HSV and HPV are the viruses causing these infections. These are causing the major death in women and newborns which need to be focused on.
In 2017, global STD testing market was valued for $ 86,548.0 million. It is predicted to reach USD 133,935.7 million by 2025, at a CAGR of 5.6% from 2018- 2025. The diagnosis of these STDs caused by Syphilis is rising and is expected to account for over 20% of the market by 2022, growing at a CAGR over the forecast period due to high prevalence of syphilis infections globally.
ALSO READ Infectious Diseases and Global Health Viral Infections Bacterial Infections Fungal Infections Vector-borne Diseases Virology and HIVAIDS Immunology and Clinical Microbiology Neurological and CNS Infections Healthcare-Associated Infections Ophthalmological Infectious Diseases Vaccines and Immunizations Tropical Diseases and Parasitic Diseases Sexually Transmitted Diseases and STIs Lower Respiratory and Pediatric IDs Pathophysiology and Diagnosis Clinical Trials and Case Studies Influencing Factors of IDs Advanced Treatments and Technologies Prevention and Control Public Health and Epidemiology Oral and Maxillofacial Infections Genomics and Infectious disease Special Session on COVID-19
Virology Conferences Clinical Microbiology Conferences Infection Control Conferences Hepatitis Conferences Infectious Diseases Conferences 2022 Infectious Diseases Conferences 2022 Influenza Conferences Infectious Diseases Conferences Infection Conferences 2022 Asia Vaccines conferences Pathology Conferences Epidemiology Conferences 2022 Communicable Diseases Conferences 2022 Infection Prevention Conferences 2022 Emerging Infectious Diseases Conferences